Using a bar-based sample, we identified factors associated with hepatitis B virus (HBV) vaccination among young African American men who have sex with men (MSM). The mean (6 standard deviation [SD]) age of the 170 participants was 26 6 6.5 years. Nearly 40% reported at least one dose of vaccine; the remainder were completely unvaccinated. Approximately 22% (37) reported having never heard of HBV. Less than 7% of participants reported using condoms the majority of the time during oral intercourse within the past 3 months, and approximately 50% reported using condoms the majority of the time during anal intercourse within the past 3 months. In multivariable analysis, variables associated with vaccination were younger age (odds ratio 
INTRODUCTION H
EPATITIS B VIRUS (HBV) infection continues to be one of the most frequently reported preventable diseases in the United States despite the licensure of a vaccine in 1982. [1] [2] [3] Currently, an estimated 1.25 million individuals are chronically infected with HBV in the United States. [4] [5] [6] [7] Sequelae resulting from chronic HBV infection include cirrhosis of the liver and hepatocellular carcinoma, and an estimated 6000 deaths occur annually from these complications. [8] [9] [10] [11] HBV can be spread both parenterally and through sexual activity. 5, 12, 13 The U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Gay and Lesbian Medical Association (GLMA) recommend vaccination against HBV for all men who have sex with men (MSM), 12, 14 a group among whom HBV has been identified as one of the most important sexually transmitted diseases (STD). 12, [15] [16] [17] [18] However, available national epidemiologic data and results from communitybased HBV vaccination programs indicate that the majority of MSM are not vaccinated. 16, 18, 19 Estimates of the prevalence of previous HBV infection in this population range from 5% to 81%; prevalence of hepatitis B surface antigen (HBsAg) vary from 1% to 11%. 20, 21 Selfreported vaccination rates among sexually active MSM are low, ranging from 11% to 48%. 15, 18, [21] [22] [23] [24] [25] [26] Recent studies examining HBV infection by race indicate that African Americans have a substantially higher incidence of new HBV infections as well as a higher level of HBV prevalence. 4, 7, 27 Unfortunately, despite the low rates of vaccination among MSM and the increased incidence and prevalence among African Americans, little is known about HBV vaccination acceptance that could help guide tailored intervention efforts. 15, 19, [21] [22] [23] [24] 28 In this study, we identified correlates of vaccination against HBV among African American MSM that could inform future interventions designed to enhance vaccination rates within this population. While the association of race with HBV incidence and prevalence presumably is a proxy for some other characteristic, understanding vaccination behavior among subgroups is essential to ensure that appropriately tailored, effective intervention strategies are designed and implemented.
METHODS
During September 2001, we anonymously collected data in two predominantly African American, male, gay bars in Birmingham, Alabama. All bar patrons were asked to participate regardless of gender by one of four trained recruiters who explained the study and assessed sobriety of potential participants using established criteria 29 to ensure informed consent. Questionnaires were self-administered and completed in secluded areas of the bars. Participants were compensated $10.00. Data collection ended at 11:30 PM each night. The data were entered twice into an electronic database and validated for data entry accuracy.
Questionnaire
Items measured demographics, health insurance coverage, sexual and nonsexual risk behaviors, vaccination status, vaccine awareness, and resources used to obtain information about hepatitis. The response categories for each item used binary, categorical or Likert-scale responses to facilitate readability and administration.
We measured frequency of condom use during oral and anal intercourse with a male partner within the past 3 months. We assessed numbers of sexual partners during the past 30 days and lifetime.
Participants reported nonsexual risk behaviors as well. Participants were asked where they had traveled internationally since 1995 because HBV vaccination is recommended for travel within some regions. [30] [31] [32] Participants were asked whether they had ever injected drugs or steroids; whether they had ever, or within the past year, shared injecting-drug equipment; whether they had received blood or blood products since 1992; and whether they had ever received a positive human immunodeficiency virus (HIV)-serologic test result. Participants also were asked whether they had ever, or in the past 5 years, been told that they had HIV or any sexually transmitted disease not including HIV.
Using a yes-no response format, we assessed whether participants had a history of testing and treatment for infection with HBV, had communicated with a health care provider about hepatitis, or had utilized various resources for information about hepatitis. Sources of information included magazines, gay media, the health department, a health care provider, family and/or friends, television, the Internet, and professional training. Scores were created (0-8) to examine whether the number of sources of information affected vaccination.
Vaccination against HBV was assessed based on each respondent's self-report of being vaccinated, regardless of whether he had completed the entire series of three injections.
Statistical analyses
Kolmogorov-Smirnov one-sample test 33 was performed to test whether the data were normally distributed. All distributions were normal at p , 0.05.
Age was collapsed into 10-year interval categories: under 20 years; 20 to 29; 30 to 39; 40 and above.
The association between dichotomous or cat-egorical predictors and HBV vaccination was assessed using the x 2 statistic or Fisher's exact test, and prevalence ratios and 95% confidence intervals were estimated. In accordance with recommended statistical practices, we entered factors associated with vaccination (at p , 0.25) into a multivariate logistic regression model. 34 Accordingly, adjusted odds ratios (OR) and confidence intervals were calculated to assess the magnitude of association between predictors and self-reported vaccination.
RESULTS
Of the participants who completed the questionnaire, 170 self-identified as African American or black and reported knowing their HBV vaccination status. The remaining participants self-identified as: white, Hispanic/Latino, or Native American; female; male and reported no same-sex sexual behaviour within the past 5 years; or, self-identified as male and reported same sex sexual behaviour within the past 5 years but reported not knowing whether they had been vaccinated against HBV.
Of the 170 participants, the mean (6 standard deviation [SD]) age was 26.3 6 6.5 years, with a range of 18 to 50 years. Nearly 40% (n 5 67) reported being vaccinated against HBV while 21.8% (n 5 37) reported never having heard of HBV.
Over half of the participants reported 10 or more different lifetime male sexual partners (n 5 115), and fewer than half reported 2 or more different male sexual partners within the past 30 days (n 5 71). More than one third (n 5 60) reported having had sex with females as well as males within the past 5 years. Not including HIV seropositivity, nearly 11.2% (n 5 19) of this sample reported a lifetime history of sexually transmitted disease (STD) diagnosis, and 5.9% (n 5 10) reported that they had received an STD diagnosis within the past 5 years. Approximately 7% (n 5 12) of the sample reported having received blood or blood products before 1992, and 4.7% (n 5 8) reported ever having injected drugs or steroids; only two participants reported ever having shared injecting drug equipment.
Twelve characteristics were associated with vaccination (Table 1) . In the multivariable model, younger age, higher educational attainment, homosexual as opposed to bisexual behaviour, and the timing of the most recent health care provider visit were associated with an increased likelihood of being vaccinated against the hepatitis B virus ( Table 2 ). The predictive power of the overall model was high (x 2 5 27.7; p 5 0.0001), correctly classifying 76.6% of the participants into their self-reported HBV vaccination status.
Enhancing awareness and facilitating vaccination among populations at risk for HBV infection are urgently needed. Although more than 40% of participants in this study reported vaccination, more than 20% reported no knowledge about HBV. Furthermore, many participants reported engaging in behaviors that put them and their sexual partners at risk for HBV infection and transmission. Given that HBV transmission can result from mucous membrane exposure to infectious body fluids including semen, 35 the low level of vaccination suggests that the failure to vaccinate this highrisk population is a missed opportunity to prevent disease.
Our results also indicated that younger participants were more likely to be vaccinated. As age increased by each 10-year interval, the odds of being vaccinated decreased by over 50%. This observation likely represents a cohort effect that reflects recent U.S. efforts in HBV vaccination that targeted infants and adolescents. 12 Similar effects also have been in reported in studies conducted in largely Caucasian populations. 19, 22 The association of HBV vaccination with higher levels of education parallels findings that report an association with being in school and HBV vaccination. 19 Possibly, this finding reflects the successful application of national infant and adolescent vaccination recommendations in the United States, 12 an increased ability of more educated individuals to assess and conceptualize their risk, or an association of education level with financial resources and insurance coverage that eliminates the financial barriers of vaccination.
The association that we found between vaccination and homosexual versus bisexual behavior may reflect the success of marketing campaigns 36 that target gay men but may not reach or seem relevant to men engaging in same-sex behavior who do not self-identify as gay. These men have been identified in the HIV research literature as difficult to identify and reach. [37] [38] [39] They may not be accessible in some gay venues, and/or they may not identify with messages that are designed to reach self-identified gay men. Developing innovative interventions is imperative to increase knowledge of, and vaccination against, HBV among MSM, especially among bisexual MSM who may not be benefiting from current educational efforts targeting self-identified gay men. 39 The apparent association between HBV vaccination and having had a recent visit to a health care provider follows other studies that have reported an association between HBV vaccination and having health insurance 40 and between HBV vaccination and visits to a com- munity health center. 19, 40 Collectively, these findings may reflect two salient issues: the importance of access to health care and therefore access to the HBV vaccine and the importance of vaccinating individuals who are at increased risk for HBV infection when they present to medical clinics and health care centers such as community clinics or STD clinics. 41 Further exploring and properly addressing these issues may require implementation of strategies at both the policy and individual practitioner levels. The former issue involves policy-level changes concerning access to health care and coverage for the costs of vaccination; while the latter issue involves individual provider practice to assess risk accurately. Because recommendation by a provider is a strong predictor of preventive behavior, 42 African American MSM must have access to care and thus the vaccine, and providers must inform patients about the efficacy and safety of the vaccine to encourage vaccination among men who screen as high risk based on their sexual and drug-use behavior. The emphasis on vaccine safety is particularly important given the negative publicity surrounding potential deleterious side effects of the HBV vaccine 43, 44 as well as the legacy of distrust for medicine and health care in the United States resulting from the Tuskegee Syphilis Study. 39, [45] [46] Furthermore, because at-risk men may need to feel comfortable discussing stigmatized risk behaviors, providers must create environments that are conducive to risk disclosure. The present study has several limitations worth noting. The associations are based on cross-sectional data; additional studies using a prospective cohort design will be necessary to evaluate the significance and stability of these findings over time. Furthermore, the results of this study may not apply to the general population of MSM. However, the degree of fit between a sample and a target population about which generalizations can be made is a common challenge in many studies; in fact, nearly all studies of sexual behavior among MSM are based on nonrandom, self-selected samples. 47, 48 Lending support for the validity of this study, the vaccination rate we observed is within the range of what other studies have reported. 15, 18, [21] [22] [23] [24] [25] [26] Although we utilized a self-administered format that may minimize response bias, these results remain based on self-reported data with their potential limitations. 49 However, techniques found to increase validity of self-reported behavior were applied. 50, 51 
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CONCLUSIONS
Based on these findings, we suggest that strategies must be developed to facilitate access to care and to increase the accurate risk assessment of patients utilizing the U.S. health care system. A recent study looking at insurance coverage found that 82.5% of U.S. citizens ages 65 years and under reported coverage by some sort of health insurance, 52 while our sample reported considerably lower health insurance coverage. Only 59% reported having some sort of insurance. Participants within this study may not have the financial resources to take preventive action. For patients with insurance coverage, determining whether one's health insurance covers HBV vaccination or denoting the most likely code to ensure insurance coverage on insurance claim forms requires extensive health care provider training, assuming that providers have accurately assessed risk initially. 39 Understanding correlates of HBV vaccination among African American MSM is not only crucial for the development and evaluation of tailored interventions aimed at increasing vaccination against HBV, but also provides the framework for developing future vaccination strategies for diseases such as HIV. While we report correlates of HBV vaccination based on a sample of African American MSM, a group about whom much behavioral data are lacking, 37-39 subsequent prospective studies must explore the potential impact of increased access to health care further; reduced costs for vaccination services; and vaccination opportunities in untraditional venues such as bars, bath houses, circuit parties, coffee shops, gyms, or house parties. House parties, in particular, have been identified as playing an influential role in social networking and behavioral norm establishment among African American MSM, 37 however, to date, house parties remain a predominately un-tapped venue for prevention activities. Furthermore, because younger men are less likely to visit a physician in general, 53 access to vaccination services in untraditional locations may be especially instrumental in increasing vaccination rates among young MSM. Focus must be placed on increasing vaccination against HBV through innovative and well-tailored strategies. A large majority of our sample reported engaging in behaviors that put them and their partners at risk for infection with HBV, yet we found many participants unaware of HBV and HBV vaccination.
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